img

Global Recombinant Human Endostatin Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Recombinant Human Endostatin Market Insights, Forecast to 2034

Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bondsCys162−302 and Cys264−294.
Global Recombinant Human Endostatin market is expected to reach to US$ 150 million in 2024, with a positive growth of %, compared with US$ 130 million in 2022. Backed with the increasing demand from downstream industries, Recombinant Human Endostatin industry is evaluated to reach US$ 238 million in 2029. The CAGR will be 8.0% during 2024 to 2029.
The market for recombinant human endostatin is important in cancer treatment. Trends include research into combination therapies and targeted cancer treatments.
Report Covers
This report presents an overview of global Recombinant Human Endostatin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Recombinant Human Endostatin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific
PeproTech
Segment by Type
Purity95%
Others

Segment by Application


Medical Care
Scientific Research
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Recombinant Human Endostatin plant distribution, commercial date of Recombinant Human Endostatin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Recombinant Human Endostatin introduction, etc. Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Recombinant Human Endostatin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Recombinant Human Endostatin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Endostatin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Purity:95%
1.2.3 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Endostatin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Medical Care
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Endostatin Sales Estimates and Forecasts 2018-2029
2.2 Global Recombinant Human Endostatin Revenue by Region
2.2.1 Global Recombinant Human Endostatin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Recombinant Human Endostatin Revenue by Region (2018-2024)
2.2.3 Global Recombinant Human Endostatin Revenue by Region (2024-2029)
2.2.4 Global Recombinant Human Endostatin Revenue Market Share by Region (2018-2029)
2.3 Global Recombinant Human Endostatin Sales Estimates and Forecasts 2018-2029
2.4 Global Recombinant Human Endostatin Sales by Region
2.4.1 Global Recombinant Human Endostatin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Recombinant Human Endostatin Sales by Region (2018-2024)
2.4.3 Global Recombinant Human Endostatin Sales by Region (2024-2029)
2.4.4 Global Recombinant Human Endostatin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant Human Endostatin Sales by Manufacturers
3.1.1 Global Recombinant Human Endostatin Sales by Manufacturers (2018-2024)
3.1.2 Global Recombinant Human Endostatin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Endostatin in 2022
3.2 Global Recombinant Human Endostatin Revenue by Manufacturers
3.2.1 Global Recombinant Human Endostatin Revenue by Manufacturers (2018-2024)
3.2.2 Global Recombinant Human Endostatin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Endostatin Revenue in 2022
3.3 Global Key Players of Recombinant Human Endostatin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Recombinant Human Endostatin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant Human Endostatin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant Human Endostatin, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant Human Endostatin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Endostatin Sales by Type
4.1.1 Global Recombinant Human Endostatin Historical Sales by Type (2018-2024)
4.1.2 Global Recombinant Human Endostatin Forecasted Sales by Type (2024-2029)
4.1.3 Global Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
4.2 Global Recombinant Human Endostatin Revenue by Type
4.2.1 Global Recombinant Human Endostatin Historical Revenue by Type (2018-2024)
4.2.2 Global Recombinant Human Endostatin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
4.3 Global Recombinant Human Endostatin Price by Type
4.3.1 Global Recombinant Human Endostatin Price by Type (2018-2024)
4.3.2 Global Recombinant Human Endostatin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Recombinant Human Endostatin Sales by Application
5.1.1 Global Recombinant Human Endostatin Historical Sales by Application (2018-2024)
5.1.2 Global Recombinant Human Endostatin Forecasted Sales by Application (2024-2029)
5.1.3 Global Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
5.2 Global Recombinant Human Endostatin Revenue by Application
5.2.1 Global Recombinant Human Endostatin Historical Revenue by Application (2018-2024)
5.2.2 Global Recombinant Human Endostatin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
5.3 Global Recombinant Human Endostatin Price by Application
5.3.1 Global Recombinant Human Endostatin Price by Application (2018-2024)
5.3.2 Global Recombinant Human Endostatin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Recombinant Human Endostatin Market Size by Type
6.1.1 US & Canada Recombinant Human Endostatin Sales by Type (2018-2029)
6.1.2 US & Canada Recombinant Human Endostatin Revenue by Type (2018-2029)
6.2 US & Canada Recombinant Human Endostatin Market Size by Application
6.2.1 US & Canada Recombinant Human Endostatin Sales by Application (2018-2029)
6.2.2 US & Canada Recombinant Human Endostatin Revenue by Application (2018-2029)
6.3 US & Canada Recombinant Human Endostatin Market Size by Country
6.3.1 US & Canada Recombinant Human Endostatin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Recombinant Human Endostatin Sales by Country (2018-2029)
6.3.3 US & Canada Recombinant Human Endostatin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant Human Endostatin Market Size by Type
7.1.1 Europe Recombinant Human Endostatin Sales by Type (2018-2029)
7.1.2 Europe Recombinant Human Endostatin Revenue by Type (2018-2029)
7.2 Europe Recombinant Human Endostatin Market Size by Application
7.2.1 Europe Recombinant Human Endostatin Sales by Application (2018-2029)
7.2.2 Europe Recombinant Human Endostatin Revenue by Application (2018-2029)
7.3 Europe Recombinant Human Endostatin Market Size by Country
7.3.1 Europe Recombinant Human Endostatin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Recombinant Human Endostatin Sales by Country (2018-2029)
7.3.3 Europe Recombinant Human Endostatin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant Human Endostatin Market Size
8.1.1 China Recombinant Human Endostatin Sales (2018-2029)
8.1.2 China Recombinant Human Endostatin Revenue (2018-2029)
8.2 China Recombinant Human Endostatin Market Size by Application
8.2.1 China Recombinant Human Endostatin Sales by Application (2018-2029)
8.2.2 China Recombinant Human Endostatin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Recombinant Human Endostatin Market Size by Type
9.1.1 Asia Recombinant Human Endostatin Sales by Type (2018-2029)
9.1.2 Asia Recombinant Human Endostatin Revenue by Type (2018-2029)
9.2 Asia Recombinant Human Endostatin Market Size by Application
9.2.1 Asia Recombinant Human Endostatin Sales by Application (2018-2029)
9.2.2 Asia Recombinant Human Endostatin Revenue by Application (2018-2029)
9.3 Asia Recombinant Human Endostatin Sales by Region
9.3.1 Asia Recombinant Human Endostatin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Recombinant Human Endostatin Revenue by Region (2018-2029)
9.3.3 Asia Recombinant Human Endostatin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant Human Endostatin Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Recombinant Human Endostatin Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Recombinant Human Endostatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Thermo Fisher Scientific Recombinant Human Endostatin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 PeproTech
11.2.1 PeproTech Company Information
11.2.2 PeproTech Overview
11.2.3 PeproTech Recombinant Human Endostatin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 PeproTech Recombinant Human Endostatin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 PeproTech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Endostatin Industry Chain Analysis
12.2 Recombinant Human Endostatin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Endostatin Production Mode & Process
12.4 Recombinant Human Endostatin Sales and Marketing
12.4.1 Recombinant Human Endostatin Sales Channels
12.4.2 Recombinant Human Endostatin Distributors
12.5 Recombinant Human Endostatin Customers
13 Market Dynamics
13.1 Recombinant Human Endostatin Industry Trends
13.2 Recombinant Human Endostatin Market Drivers
13.3 Recombinant Human Endostatin Market Challenges
13.4 Recombinant Human Endostatin Market Restraints
14 Key Findings in The Global Recombinant Human Endostatin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Recombinant Human Endostatin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Purity:95%
Table 3. Major Manufacturers of Others
Table 4. Global Recombinant Human Endostatin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Recombinant Human Endostatin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Recombinant Human Endostatin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Recombinant Human Endostatin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Recombinant Human Endostatin Revenue Market Share by Region (2018-2024)
Table 9. Global Recombinant Human Endostatin Revenue Market Share by Region (2024-2029)
Table 10. Global Recombinant Human Endostatin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Recombinant Human Endostatin Sales by Region (2018-2024) & (K Pcs)
Table 12. Global Recombinant Human Endostatin Sales by Region (2024-2029) & (K Pcs)
Table 13. Global Recombinant Human Endostatin Sales Market Share by Region (2018-2024)
Table 14. Global Recombinant Human Endostatin Sales Market Share by Region (2024-2029)
Table 15. Global Recombinant Human Endostatin Sales by Manufacturers (2018-2024) & (K Pcs)
Table 16. Global Recombinant Human Endostatin Sales Share by Manufacturers (2018-2024)
Table 17. Global Recombinant Human Endostatin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Recombinant Human Endostatin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Recombinant Human Endostatin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Recombinant Human Endostatin Price by Manufacturers 2018-2024 (USD/Pcs)
Table 21. Global Recombinant Human Endostatin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Recombinant Human Endostatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Endostatin as of 2022)
Table 23. Global Key Manufacturers of Recombinant Human Endostatin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Recombinant Human Endostatin, Product Offered and Application
Table 25. Global Key Manufacturers of Recombinant Human Endostatin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human Endostatin Sales by Type (2018-2024) & (K Pcs)
Table 28. Global Recombinant Human Endostatin Sales by Type (2024-2029) & (K Pcs)
Table 29. Global Recombinant Human Endostatin Sales Share by Type (2018-2024)
Table 30. Global Recombinant Human Endostatin Sales Share by Type (2024-2029)
Table 31. Global Recombinant Human Endostatin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Recombinant Human Endostatin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Recombinant Human Endostatin Revenue Share by Type (2018-2024)
Table 34. Global Recombinant Human Endostatin Revenue Share by Type (2024-2029)
Table 35. Recombinant Human Endostatin Price by Type (2018-2024) & (USD/Pcs)
Table 36. Global Recombinant Human Endostatin Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 37. Global Recombinant Human Endostatin Sales by Application (2018-2024) & (K Pcs)
Table 38. Global Recombinant Human Endostatin Sales by Application (2024-2029) & (K Pcs)
Table 39. Global Recombinant Human Endostatin Sales Share by Application (2018-2024)
Table 40. Global Recombinant Human Endostatin Sales Share by Application (2024-2029)
Table 41. Global Recombinant Human Endostatin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Recombinant Human Endostatin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Recombinant Human Endostatin Revenue Share by Application (2018-2024)
Table 44. Global Recombinant Human Endostatin Revenue Share by Application (2024-2029)
Table 45. Recombinant Human Endostatin Price by Application (2018-2024) & (USD/Pcs)
Table 46. Global Recombinant Human Endostatin Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 47. US & Canada Recombinant Human Endostatin Sales by Type (2018-2024) & (K Pcs)
Table 48. US & Canada Recombinant Human Endostatin Sales by Type (2024-2029) & (K Pcs)
Table 49. US & Canada Recombinant Human Endostatin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Recombinant Human Endostatin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Recombinant Human Endostatin Sales by Application (2018-2024) & (K Pcs)
Table 52. US & Canada Recombinant Human Endostatin Sales by Application (2024-2029) & (K Pcs)
Table 53. US & Canada Recombinant Human Endostatin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Recombinant Human Endostatin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Recombinant Human Endostatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Recombinant Human Endostatin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Recombinant Human Endostatin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Recombinant Human Endostatin Sales by Country (2018-2024) & (K Pcs)
Table 59. US & Canada Recombinant Human Endostatin Sales by Country (2024-2029) & (K Pcs)
Table 60. Europe Recombinant Human Endostatin Sales by Type (2018-2024) & (K Pcs)
Table 61. Europe Recombinant Human Endostatin Sales by Type (2024-2029) & (K Pcs)
Table 62. Europe Recombinant Human Endostatin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Recombinant Human Endostatin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Recombinant Human Endostatin Sales by Application (2018-2024) & (K Pcs)
Table 65. Europe Recombinant Human Endostatin Sales by Application (2024-2029) & (K Pcs)
Table 66. Europe Recombinant Human Endostatin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Recombinant Human Endostatin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Recombinant Human Endostatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Recombinant Human Endostatin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Recombinant Human Endostatin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Recombinant Human Endostatin Sales by Country (2018-2024) & (K Pcs)
Table 72. Europe Recombinant Human Endostatin Sales by Country (2024-2029) & (K Pcs)
Table 73. China Recombinant Human Endostatin Sales by Type (2018-2024) & (K Pcs)
Table 74. China Recombinant Human Endostatin Sales by Type (2024-2029) & (K Pcs)
Table 75. China Recombinant Human Endostatin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Recombinant Human Endostatin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Recombinant Human Endostatin Sales by Application (2018-2024) & (K Pcs)
Table 78. China Recombinant Human Endostatin Sales by Application (2024-2029) & (K Pcs)
Table 79. China Recombinant Human Endostatin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Recombinant Human Endostatin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Recombinant Human Endostatin Sales by Type (2018-2024) & (K Pcs)
Table 82. Asia Recombinant Human Endostatin Sales by Type (2024-2029) & (K Pcs)
Table 83. Asia Recombinant Human Endostatin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Recombinant Human Endostatin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Recombinant Human Endostatin Sales by Application (2018-2024) & (K Pcs)
Table 86. Asia Recombinant Human Endostatin Sales by Application (2024-2029) & (K Pcs)
Table 87. Asia Recombinant Human Endostatin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Recombinant Human Endostatin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Recombinant Human Endostatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Recombinant Human Endostatin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Recombinant Human Endostatin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Recombinant Human Endostatin Sales by Region (2018-2024) & (K Pcs)
Table 93. Asia Recombinant Human Endostatin Sales by Region (2024-2029) & (K Pcs)
Table 94. Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Type (2018-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Type (2024-2029) & (K Pcs)
Table 96. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Application (2018-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Application (2024-2029) & (K Pcs)
Table 100. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Country (2018-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Recombinant Human Endostatin Sales by Country (2024-2029) & (K Pcs)
Table 107. Thermo Fisher Scientific Company Information
Table 108. Thermo Fisher Scientific Description and Major Businesses
Table 109. Thermo Fisher Scientific Recombinant Human Endostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Thermo Fisher Scientific Recombinant Human Endostatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Thermo Fisher Scientific Recent Developments
Table 112. PeproTech Company Information
Table 113. PeproTech Description and Major Businesses
Table 114. PeproTech Recombinant Human Endostatin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. PeproTech Recombinant Human Endostatin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. PeproTech Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Recombinant Human Endostatin Distributors List
Table 120. Recombinant Human Endostatin Customers List
Table 121. Recombinant Human Endostatin Market Trends
Table 122. Recombinant Human Endostatin Market Drivers
Table 123. Recombinant Human Endostatin Market Challenges
Table 124. Recombinant Human Endostatin Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human Endostatin Product Picture
Figure 2. Global Recombinant Human Endostatin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Recombinant Human Endostatin Market Share by Type in 2022 & 2029
Figure 4. Purity:95% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Recombinant Human Endostatin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Recombinant Human Endostatin Market Share by Application in 2022 & 2029
Figure 8. Medical Care
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Recombinant Human Endostatin Report Years Considered
Figure 12. Global Recombinant Human Endostatin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Recombinant Human Endostatin Revenue 2018-2029 (US$ Million)
Figure 14. Global Recombinant Human Endostatin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Recombinant Human Endostatin Revenue Market Share by Region (2018-2029)
Figure 16. Global Recombinant Human Endostatin Sales 2018-2029 ((K Pcs)
Figure 17. Global Recombinant Human Endostatin Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Recombinant Human Endostatin Sales YoY (2018-2029) & (K Pcs)
Figure 19. US & Canada Recombinant Human Endostatin Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Recombinant Human Endostatin Sales YoY (2018-2029) & (K Pcs)
Figure 21. Europe Recombinant Human Endostatin Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Recombinant Human Endostatin Sales YoY (2018-2029) & (K Pcs)
Figure 23. China Recombinant Human Endostatin Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Recombinant Human Endostatin Sales YoY (2018-2029) & (K Pcs)
Figure 25. Asia (excluding China) Recombinant Human Endostatin Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Recombinant Human Endostatin Sales YoY (2018-2029) & (K Pcs)
Figure 27. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Recombinant Human Endostatin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Recombinant Human Endostatin in the World: Market Share by Recombinant Human Endostatin Revenue in 2022
Figure 30. Global Recombinant Human Endostatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
Figure 32. Global Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
Figure 33. Global Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
Figure 34. Global Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Recombinant Human Endostatin Revenue Share by Country (2018-2029)
Figure 40. US & Canada Recombinant Human Endostatin Sales Share by Country (2018-2029)
Figure 41. U.S. Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
Figure 44. Europe Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
Figure 45. Europe Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
Figure 46. Europe Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
Figure 47. Europe Recombinant Human Endostatin Revenue Share by Country (2018-2029)
Figure 48. Europe Recombinant Human Endostatin Sales Share by Country (2018-2029)
Figure 49. Germany Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 50. France Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 54. China Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
Figure 55. China Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
Figure 56. China Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
Figure 57. China Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
Figure 58. Asia Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
Figure 59. Asia Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
Figure 60. Asia Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
Figure 61. Asia Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
Figure 62. Asia Recombinant Human Endostatin Revenue Share by Region (2018-2029)
Figure 63. Asia Recombinant Human Endostatin Sales Share by Region (2018-2029)
Figure 64. Japan Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 68. India Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Recombinant Human Endostatin Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Recombinant Human Endostatin Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Recombinant Human Endostatin Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Recombinant Human Endostatin Sales Share by Country (2018-2029)
Figure 75. Brazil Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Recombinant Human Endostatin Revenue (2018-2029) & (US$ Million)
Figure 80. Recombinant Human Endostatin Value Chain
Figure 81. Recombinant Human Endostatin Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed